Les tests de diagnostic rapide en biochimie médicale : intérêts, limites et dangers

Revue Francophone des Laboratoires - Tập 2015 - Trang 31-38 - 2015
Bruno Baudin1
1Biochimie A – Pôle Biologie médicale et pathologie, Hôpitaux universitaires de, l’Est Parisien (AP-HP), Site Saint-Antoine, 184, rue du Faubourg Saint-Antoine, 75571 Paris cedex 12, et INSERM UMR S 1193 – UFR Pharmacie – Châtenay-Malabry, Université Paris-Sud

Tài liệu tham khảo

Benaderette, 2013, Tests de dépistage rapide : sus à la brèche dans le circuit de la biologie médicale, OptionBio, 494, 1 Lenters-Westra, 2010, Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria, Clin Chem, 56, 44, 10.1373/clinchem.2009.130641 Braga, 2011, Revaluation of biological variation of glycated hemoglobin (HbA1c) using accurately designed protocol and an assay traceable to the IFCC reference system, Clin Chim Acta, 412, 1412, 10.1016/j.cca.2011.04.014 Bassand, 2007, Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European society of cardiology, Eur Heart J, 28, 1598, 10.1093/eurheartj/ehm161 Pearson, 2010, In acute coronary syndromes, heart-type fatty acid binding protein is a more accurate predictor of long term prognosis than troponin, Circulation, 122, A11374 Lefèvre, 2009, Marqueurs biochimiques du syndrome coronarien aigu (SCA), Rev Fr Lab, 409, 51 Baudin, 2013, L’exploration du rein en 2013, Rev Fr Lab, 451, 39